Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Savior LifetecROCO:4167 -0.74%69 Days Payable is 22.65 as of Jun. 2026, which is 5% below its 10-year median of 23.91. GuruFocus rates ROCO:4167 with a GF Score™ of 69/100 and a GF Value™ of NT$18.25 (Fairly Valued). The stock has 6 warning signs investors should review. Among 708 Biotechnology companies, Savior Lifetec ranks worse than 84.6% on this metric.
The historical data trend for Savior Lifetec's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4167 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Savior Lifetec's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Savior Lifetec Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Savior Lifetec's Days Payable distribution charts can be found below:
* The bar in red indicates where Savior Lifetec's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Savior Lifetec's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Savior Lifetec (ROCO:4167) has a Days Payable of 22.65 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Savior Lifetec and its competitors. This is near median its historical median of 23.91. Over the past decade, Savior Lifetec's Days Payable has ranged from 18.16 to 47.04. According to the industry distribution chart, Savior Lifetec ranks #599 out of 708 companies in the Biotechnology industry, placing it in the top 84.6%.
Is Savior Lifetec's Days Payable too high?
Savior Lifetec's current Days Payable of 22.65 is near median its 10-year median of 23.91. Over the past 10 years, this metric has ranged from a low of 18.16 to a high of 47.04. The Biotechnology industry median Days Payable is 111.17. Savior Lifetec's value of 22.65 is 79.6% below this industry median. Based on the distribution chart, Savior Lifetec ranks #599 out of 708 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Savior Lifetec has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savior Lifetec's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Savior Lifetec ranks #599 out of 708 companies for Days Payable. This places Savior Lifetec in the lower half of its industry. The industry median Days Payable is 111.17. Savior Lifetec's value of 22.65 is 79.6% below this benchmark. Historically, Savior Lifetec's own Days Payable has ranged from 18.16 to 47.04 over the past decade. While the company's 10-year median is 23.91 vs. the industry median of 111.17, Savior Lifetec has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.17, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Savior Lifetec's current Days Payable of 22.65 is 79.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Savior Lifetec and its competitors. For the Biotechnology industry, the median Days Payable is 111.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Savior Lifetec's current Days Payable is 22.65, which is near median its own 10-year median of 23.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savior Lifetec stock overvalued right now?
Based on GuruFocus' analysis, Savior Lifetec (ROCO:4167) is currently considered Fairly Valued. The stock's GF Value™ is NT$18.25, compared to a current price of NT$20.00 — trading 9.6% above its estimated fair value. The current Days Payable is 22.65, which is near median its 10-year median of 23.91 and 79.6% below the Biotechnology industry median of 111.17. Savior Lifetec's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Savior Lifetec (ROCO:4167), the current Days Payable is 22.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Savior Lifetec (ROCO:4167) Overvalued in 2026?
Based on GuruFocus' analysis, Savior Lifetec stock appears to be overvalued.
The current stock price of NT$20.00 is trading 9.6% above its estimated GF Value™ of NT$18.25.
GuruFocus considers Savior Lifetec to be Fairly Valued.
Key valuation signals for ROCO:4167:
Days Payable: 22.65 (near median its 10-year median of 23.91)
GF Value™: NT$18.25 vs. price of NT$20.00 (9.6% above fair value)
Industry Position: 79.6% below the Biotechnology median (#599 of 708)
No single metric tells the full story. See the ROCO:4167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Savior Lifetec Corp is engaged in the research, development, design, manufacture, and sale of carbapenem generics, injection generics, controlled-release generics, development of new dosage forms and drugs, and the APIs, excipients, intermediates, and dosage forms of the aforementioned products. The company also provides medicine manufacturer technology and services. The company geographically operates in four regions: the Americas, Asia, Taiwan, and Europe.
69GF Score
Get the complete analysis for ROCO:4167
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4167 has been successfully added to your 
